Task and functions

Címlap >> Content >> Task and functions

According to the functions set down in its charter, the National Institute of Oncology of Budapest is the methodological, organizational, cancer prevention, training, treatment, and scientific co-ordinating centre for Hungarian oncology.

The Institute conducts its treatment activities at ten inpatient and four diagnostic departments, with the assistance of 922 people, utilizing 344 beds. In compliance with the European requirements for accreditation, the Institute hosts separate departments for radiotherapy, chemotherapy, histopathology, diagnostic imaging, and nuclear medicine.

Main characteristics of the clinical activities of the National Institute of Oncology

Number of outpatient visits Inpatients (total)
2005 212,496 13,141
2006 421,017 27,403
2007 545,044 38,711
2008 528,755 40,347
Utilization of beds: 74%
Number of beds: 344 (OEP contracted)
Average treatment time: 5.97 days

The most important parameter of the Institute's activity is that it is capable of providing the patients with complex oncotherapeutic (surgery, chemotherapy, and radiotherapy) treatment. The staff and material facilities of state-of-the-art tumour diagnostics (CT, MRI, imaging, laboratory, and pathology) offer high-quality diagnostic and monitoring possibilities through the assistance of the expert team skilled in imaging, laboratory, and pathological diagnostics and the state-of-the-art diagnostic instruments (CT, MRI, and angiography).

In line with its professional coordinating functions, the Institute has prepared and maintained the following methodological guides, following the guidelines of the European Union:

  1. National Cancer Control Programme.
  2. Oncotherapeutic Protocol, The guidelines for oncology.
  3. The guidelines for tumour screening in Hungary.
  4. The quality control for the treatment of patients with malignant tumours.
  5. The university textbook entitled The basics of oncology
  6. Consensus conferences: the treatment of cervical, breast, colorectal, pulmonary tumours and melanoma as well as those in the oral cavity; rational application of PET-CT examinations, HPV vaccination.

These programmes have been normative in all fields of the fight against malignant tumours.

The Institute presently has six research departments, with a staff of 71 persons. The majority of the research studies is applied clinical research, whose results are continuously being integrated into the Institute's preventive and curative activities.

The clinical and research background of the Institute provides a unique opportunity for the theoretical and practical training in oncology, both at the graduate and post-graduate level. The which was hosted by the Institute, devised the draft curriculum for the graduate and post-graduate education in Clinical oncology. The curriculum was developed taking into account both the European and American methods of training oncology specialists. The syllabus for the Department of Onco-therapy at the Institute comprises a multidisciplinary training programme, which, apart from the clinical knowledge necessary for the early diagnosis and complex therapy of malignant tumours, includes recent findings from basic research dealing with the prevention and development of malignant tumours.

The Institute, as the professional, methodological, and research centre, has established international connections that promote the international integration of Hungarian clinical oncology and tumour research. The Institutes participates in a number of interstate agreements and international grant proposals, and it maintains contacts with the international health organizations (WHO, UICC, OECI, EACR, and EORTC).

These international contacts promote the European integration of the discipline of oncology.

The economic and technical funding of the Institute is ensured by the National Health Insurance Fund (OEP) contract. Additional funding for the national and research activities is provided by the Ministry of Health. The operational, investment, and personal incentives plan established in line with the funding conditions, in a cost sensitive manner, ensured relatively smooth and successful management. Even with the strict management, the required pharmaceuticals and medical substances were available, along with the protective devices, equipment, and protective drinks necessary for the treatment of patients and carrying out the day-to-day activities.

In conclusion, the Institute successfully satisfied the requirements that may be justly expected of the top-level institute for progressive oncological treatment. As a consequence of the Institute's organizational and methodological activities, the guidelines for County Oncology Centres were developed. The clinical and research activities are outstanding even by international standards. Owing to the successfully applied controlling activities, the Institute's management was successful and free of liquidity issues. The screening, methodological, and treatment activities of the Institute fulfill governmental functions. At the same time, however, the clinical and research background provide a unique opportunity for providing theoretical and practical training in oncology, both at the graduate and at the post-gradutate level, as well as the national coordination of oncology-related research projects.

Based on all these, the National Institute of Oncology is the top-level institute of the treatment of patients with malignant tumours.